AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Park Ha Biological Technology Co., Ltd. (PHH) shares plunge 64.55% to record low
Generated by AI AgentAinvest Movers Radar
Wednesday, Jul 9, 2025 7:32 pm ET1min read
Park Ha Biological Technology Co., Ltd. (PHH) shares plummeted to a record low today, with an intraday decline of 64.55%. The stock has been on a downward spiral, dropping 63.21% over the past two days, resulting in a cumulative decline of 97.32% over the same period.
PHH shares were halted due to a circuit breaker event, resulting in a significant downward movement in the stock's price. This halt indicates heightened volatility or other market factors affecting the company's stock.
PHH has been one of the worst performers in the U.S. stock market, with substantial declines in its stock price. The company's stock has experienced dramatic decreases, suggesting severe financial or operational issues. These declines have contributed to the negative sentiment surrounding the company.
PHH was listed as a top stock loser in the past week, showing a decline of 96.18%. This further emphasizes the company's recent struggles and the negative market sentiment surrounding its stock.
Ainvest Movers Radar
Knowing stock market today at a glance
Latest Articles
Two Harbors (TWO) Surges 1.59% to Monthly High Amid Anticipation of $1.3B UWM Acquisition
Dec.19 2025
Trane Technologies Surges 1.46% on Q3 Earnings, Analysts Target $550
Dec.19 2025
Rivian (RIVN) Surges 27.34% on Analyst Upgrades, Q3 Revenue Growth Drives Rebound
Dec.19 2025
Tata Chemicals Share Price Soars 119.32% on Novabay Acquisition Drive
Dec.19 2025
X3 Holdings (XTKG) Rallies 36.76% Intraday, 22.50% in Three Sessions on Technical Rebound and Speculative Buying
Dec.19 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet